Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer
Authors:
Open Access
- 14 January 2016
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 57 (4) , 563-567
Abstract
Purpose: We evaluated the diagnostic value and accuracy of prostate specific membrane antigen (PSMA) positron emission tomography (PET) for the intraprostatic delineation of prostate cancer prior to prostatectomy. Methods: We identified a total of six patients with biopsy proven high risk prostate cancer, who were referred to 68Ga-PSMA-PET/CT prior to radical prostatectomy to rule out metastases. After prostatectomy, a histology map of the prostate was reconstructed. The histological extension and Gleason Score of each segment of the prostate were compared with PSMA-PET images, resliced to the histological axis. Sensitivity, specificity, positive predictive value, negative predictive value, positive and negative likelihood ratios were calculated. Standard uptake value of each segment was measured and median values were compared. Results: 112/132 segments were eligible for analysis. The correlation of histological results with PSMA-PET images showed a specificity and sensitivity of 92%, respectively. The positive and negative likelihood ratio and the positive and negative predictive value for PSMA-PET detecting prostate cancer were 11.5, 0.09, 96% and 85%, respectively. The median maximum standard uptake value of true positive prostate segments was significantly higher than in true negative segments (11.0±7.8 vs. 2.7±0.9, pConclusion: These preliminary results show that the intraprostatic localization and extent of prostate cancer may be estimated by PSMA-PET. This imaging method may be helpful for identifying target lesions prior to prostate biopsy and may support decision-making prior to focal or radical prostate cancer therapy.Keywords
This publication has 22 references indexed in Scilit:
- [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECHEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimensBMC Medical Informatics and Decision Making, 2010
- Skin Tumours2010
- The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): Design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancerContemporary Clinical Trials, 2009
- Guidelines for the macroscopic processing of radical prostatectomy and pelvic lymphadenectomy specimensJournal of Clinical Pathology, 2008
- Implementation of a map in radical prostatectomy specimen allows visual estimation of tumor volumeEuropean Journal of Surgical Oncology, 2007
- Update on the Gleason Grading System for Prostate CancerAdvances in Anatomic Pathology, 2006
- A dual-monoclonal sandwich assay for prostate-specific membrane antigen: Levels in tissues, seminal fluid and urineThe Prostate, 2000
- Upregulation of prostate-specific membrane antigen after androgen-deprivation therapyUrology, 1996
- Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluidsInternational Journal of Cancer, 1995